| 臺大學術典藏 |
2021-01-04T12:13:09Z |
Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan
|
HWEI-FANG TIEN; Huang S.-Y.; Tang J.-L.; Liang Y.-J.; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:09Z |
Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans-retinoic acid treatment
|
HWEI-FANG TIEN; Chen Y.-C.; Shen M.-C.; Lin M.-T.; Wang C.-H.; Lee F.-Y.; Liang Y.-J.; Yao M.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:09Z |
Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas
|
HWEI-FANG TIEN; Su I.J.; Tang J.-L.; Liu M.-C.; Lee F.-Y.; Chen Y.-C.; Chuang S.-M. |
| 臺大學術典藏 |
2021-01-04T12:13:08Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
HWEI-FANG TIEN; Lin M.-T.; Tang J.-L.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:06Z |
Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years
|
HWEI-FANG TIEN; Shen M.-C.; Chen Y.-C.; Wang C.-H.; Lin K.-S.; Lin K.-S.; Huang S.-Y.; Tang J.-L.; Jou S.-T.; Tsay W.; Hu C.-H.; Lin D.-T. |
| 臺大學術典藏 |
2021-01-04T12:13:06Z |
Clonal disease of natural killer large granular lymphocytes in Taiwan
|
HWEI-FANG TIEN; Chuang S.-M.; Shen M.-C.; Wang C.-H.; Lee F.-Y.U.; Liu M.-C.; Chen Y.-C.; Huang S.-Y.I.; Su I.-J.; Tang J.-L.; Chiang I.-P.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:06Z |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
|
Chen Y.-C.; Shen M.-C.; Wang C.-H.; Chung C.-Y.; Yao Y.U.-T.; Chou W.-C.; Kuo T.-L.I.; Huang S.-F.; HWEI-FANG TIEN; Tang J.-L.; Chang C.-S.; Huang S.-Y.I. |
| 臺大學術典藏 |
2021-01-04T12:13:05Z |
Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndrome
|
Hsu C.; Lin M.-T.; Tang J.-L.; HWEI-FANG TIEN; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23
|
HWEI-FANG TIEN; Wang D.-T. C.-H. -au Shen, Lin K.-H.; Chen Y.-C.; Yao M.; Tsay W.; Huang S.-Y.; Tang J.-L.; Kuo Y.-Y.; Shiah H.-S. |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Liu M.-Y.; Cheng A.-L.; Hsu C.-H.; Wang C.-H.; Tang J.-L.; Yeh K.-H.; Kao W.-Y.; Huang M.-C.; Chang M.-C.; HWEI-FANG TIEN; Chao T.-Y.; Lin Z.-Z.; Su I.-J.; Huang C.-L. |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Methylation of the p15INK4B gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation
|
Liu M.-C.; Lee F.-Y.; Tsay W.; Tang J.-L.; HWEI-FANG TIEN; Wang C.-H.; Chen Y.-C.; Shen M.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
|
Tang J.-L.; Ko B.-S.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:03Z |
Marrow matrix metalloproteinases (MMPS) and tissue inhibitors of MMP in acute leukaemia: Potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia
|
Lee C.-Y.; Tang J.-L.; Chang C.-J.; Lin D.-T.; Lin L.-I.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:03Z |
High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan
|
Hsiao C.-H.; Tang J.L.; Yao M.; Tsay W.; Wang C.-H.; Chen Y.-C.; Shen M.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:03Z |
Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan
|
Ko B.-S.; Tang J.-L.; Lee F.-Y.; Liu M.-C.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:02Z |
Splenic actinomycotic abscess in a patient with acute myeliod leukemia
|
HWEI-FANG TIEN; Lin W.-C.; Su I.-J.; Tang J.-L.; Chen Y.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:13:01Z |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Tang J.-L.; Chen Y.-C.; Cheng A.-L.; Chang S.-M.; HWEI-FANG TIEN; Hwang J.-S.; Wang J.-D.; Hsu C. |
| 臺大學術典藏 |
2021-01-04T12:13:01Z |
SOCSI methylation in patients with newly diagnosed acute myeloid leukemia
|
Yao M.; Huang S.-Y.; Lin S.-W.; Shen H.-L.; Tang J.-L.; Tsay W.; Chen C.-Y.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:59Z |
Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells
|
Tsay W.; Tang J.-L.; Lin D.-T.; Chen C.-Y.; Lin L.-I.; Yeh Y.-C.; Shen H.-L.; Su F.-H.; Yao M.; Huang S.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:59Z |
Chromosomal abnormalities of 200 Chinese patients with non-Hodgkins's lymphoma in Taiwan: With special reference to T-cell lymphoma
|
Lee F.-Y.; Su I.-J.; Wang C.-C.; Chou W.-C.; Tsay W.; Tang J.-L.; Yao M.; Chen C.-Y.; Liu M.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:59Z |
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy
|
HWEI-FANG TIEN; Chang S.-C.; Tsai W.; Shen M.-C.; Wang C.-H.; Chen Y.-C.; Chen Y.-C.; Huang S.-Y.; Yao M.; Hsueh P.-R.; Tang J.-L.; Chen C.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2021-01-04T12:12:58Z |
Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan
|
Liu M.-C.; Wang C.-H.; Lee F.-Y.; Tsay W.; Yao M.; Tang J.-L.; Huang S.-Y.; Chen Y.-C.; Shen M.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:57Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
HWEI-FANG TIEN; Lin K.-H.; Lin D.-T.; Chen Y.-C.; Ko B.-S.; Yao M.; Chiou R.-J.; Huang C.-F.; Yeh Y.-C.; Chang H.-H.; Tsay W.; Lin L.-I.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Huang S.-Y.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Tang J.-L.; Yao M.; Wu S.-J.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
HWEI-FANG TIEN; Huang C.-F.; Chen C.-Y.; Huang S.-Y.; Huang K.-C.; Yao M.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:53Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Chen Y.-C.; Yao M.; Huang S.-Y.; Tsay W.; Chen C.-Y.; Tang J.-L.; Hsu C.; Huang T.-C.; Ko B.-S.; HWEI-FANG TIEN; Shen M.-C.; Wang C.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia
|
Chen Y.-C.; HWEI-FANG TIEN; Tang J.-L.; Ko B.-S.; Yao M.; Wu S.-J. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Chen Y.-K.; Tang J.-L.; Yao M.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; HWEI-FANG TIEN; Chang H.-H.; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:46Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Tang J.-L.; Chen B.-B.; Liu C.-Y.; Shih T.T.F.; Hou H.-A.; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu C.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:44Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chen C.-Y.; Lin C.-W.; Jhuang J.-Y.; Cheng C.-L.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:43Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:41Z |
Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
|
Chen C.-Y.; Chou W.-C.; Tsay W.; Tang J.-L.; Yao M.; Huang S.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:37Z |
Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement
|
Chiou T.-J.; Chen T.Y.; Chang C.-S.; Chang M.-C.; Ko B.-S.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:34Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Chen C.-Y.; Sheng W.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:32Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Sheng W.-H.; Tang J.-L.; Yao M.; Chou W.-C.; Cheng A.; Huang S.-Y.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:31Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Lin H.-H.; Huang S.-Y.; Tsay W.; Lu H.-Y.; Ko B.-S.; Hsu S.-C.; Chou W.-C.; Chou S.-C.; Hou H.-A.; Wu S.-J.; Yao M.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:24Z |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Chiang Y.-C.; Tseng M.-H.; Kuo Y.-Y.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tsai C.-H.; Lin T.-Y.; Hou H.-A.; Lu J.-W.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:23Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Ko B.-S.; Huang S.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Chen C.-Y.; Chou W.-C.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Kuo Y.-Y.; Wu S.-J.; Hou H.-A.; Tsai C.-H.; Hsu S.-C.; Lin C.-T.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:22Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Vaccines; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Ko B.-S.; Chen W.-T.; Kung H.-C.; Wu U.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; HWEI-FANG TIEN; Chang S.-C.; Chuang Y.-C.; Lin D.-T.; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood |
| 臺大學術典藏 |
2021-01-04T12:12:21Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HWEI-FANG TIEN; Chou W.-C.; Yao M.; Huang S.-Y.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Tang J.-L.; HWEI-FANG TIEN; Li C.-C.; Hsu C.-A.; Ko B.-S.; Yao M.; Wu S.-J.; Lin C.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Wu S.-J.; Tsai C.-H.; Huang T.-C.; Lin C.-T.; Liu J.-H.; Yao M.; Huang H.-H.; Hou H.-A.; Hsu S.-C.; Weng P.-F.; Li C.-C.; Li J.-L.; Ko B.-S.; Wang Y.-F.; Huang S.-Y.; Chou W.-C.; HWEI-FANG TIEN; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-04T12:12:19Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Chiu Y.-C.; Kuo Y.-Y.; Tien F.-M.; Tang J.-L.; Yao C.-Y.; Tsai C.-H.; HWEI-FANG TIEN; Hou H.-A.; Chen C.-Y.; Lin L.-I.; Chou W.-C.; Yao M.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Lin C.-C.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:18Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Tseng M.-H.; HWEI-FANG TIEN; Huang S.-Y.; Chen C.-Y.; Hsu S.-C.; Wu S.-J.; Tsay W.; Yao M.; Li C.-C.; Tang J.-L.; Lin C.-T.; Ko B.-S.; Chou W.-C.; Hou H.-A.; Huang H.-H.; Chen F.-Y.; Chen R.-H. |
